Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA)
Neurologische Outcomes unter Hypothermie versus Normothermie bei Patient:innen mit moderater initialer Krankheits-schwere nach Reanimation nach außerklinischem Herzstillstand: Protokoll einer multizentrischen randomisierten kontrollierten Studie (R-CAST OHCA)
BMJ Open · 2025-08 · 15 (8) · e101809
DOI: 10.1136/bmjopen-2025-101809 ↗Auf einen Blick
Die R-CAST-OHCA-Studie prüft, ob Hypothermie gegenüber Normothermie 30-Tage-neurologische Outcomes bei Patient:innen mit moderater PCAS-Schwere nach außerklinischem Herzstillstand verbessert.
Fragestellung
Verbessert Hypothermie im Vergleich zu Normothermie die 30-Tage-neurologischen Outcomes bei Patient:innen mit moderat schwerem PCAS nach außerklinischem Herzstillstand?
Methode
Multizentrische, einfach verblindete, parallele, überlegene RCT an 35 Zentren; Randomisierung innerhalb von 3 Stunden nach ROSC. Hypothermie 34°C bis 28 Stunden, dann Wiedererwärmung auf 37°C.
Ergebnisse
Geplant sind 380 Teilnehmende. Primärer Endpunkt ist ein günstiges neurologisches Outcome (CPC 1 oder 2) 30 Tage nach Randomisierung; Auswertung nach Intention-to-treat.
Einschränkungen
Es handelt sich um ein Studienprotokoll; Ergebnisse liegen noch nicht vor.
Schlussfolgerung der Autor:innen
Das Studienziel ist der Vergleich von Hypothermie und Normothermie zur Verbesserung neurologischer Outcomes bei moderat schwerem PCAS nach OHCA.
Kernaussagen
- Hypothermie vs. Normothermie bei moderat schwerem PCAS nach OHCA
- Multizentrische, einfach verblindete, parallele RCT
- Primärer Endpunkt: CPC 1 oder 2 nach 30 Tagen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BMJ Open, online erschienen am 22.08.2025. Verfasst von Hiromichi Naito und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, …. Hauptthemen laut MEDLINE: Hypothermia, Induced, Out-of-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation, Post-Cardiac Arrest Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Themen: Reanimation
Abstract (Originalsprache)
Introduction Temperature control is a fundamental intervention for neuroprotection following resuscitation from cardiac arrest. However, evidence regarding the efficacy of hypothermia in post-cardiac arrest syndrome (PCAS) remains unclear. Retrospective studies suggest that the clinical effectiveness of hypothermia may depend on the severity of PCAS. The R-CAST OHCA trial aims to compare the efficacy of hypothermia versus normothermia in improving 30-day neurological outcomes in patients with moderately severe PCAS following out-of-hospital cardiac arrest. Methods and analysis The multicentre, single-blind, parallel-group, superiority, randomised controlled trial (RCT) is conducted with the participation of 35 emergency and critical care centres and/or intensive care units at academic and non-academic hospitals. The study enrols moderately severe PCAS patients, defined as those with a revised post-Cardiac Arrest Syndrome for induced Therapeutic Hypothermia score of 5.5–15.5. A target number of 380 participants will be enrolled. Participants are randomised to undergo either hypothermia or normothermia within 3 hours after return of spontaneous circulation. Patients in the hypothermia group are cooled and maintained at 34°C until 28 hours post-randomisation, followed by rewarming to 37°C at a rate of 0.25°C/hour. Patients in the normothermia group are maintained at normothermia (36.5°C–37.7°C). Total periods of intervention, including the cooling, maintenance and rewarming phases, will occur 40 hours after randomisation. Other treatments for PCAS can be determined by the treating physicians. The primary outcome is a favourable neurological outcome, defined as Cerebral Performance Category 1 or 2 at 30 days after randomisation and compared using an intention-to-treat analysis. Ethics and dissemination This study has been approved by the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee (approval number: R2201-001). Written informed consent is obtained from all participants or their authorised surrogates. Results will be disseminated via publications and presentations. Trial registration number jRCT1062220035.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan naito.hiromichi@gmail.com.
- Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Emergency and Critical Care Medicine, Aichi Medical University, Nagakute, Japan.
- Department of Preventive Services, School of Public Health, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Health Services and Systems Research, Duke-NUS Medical School, Singapore.
- Department of Emergency and Critical Care Medicine, Tsuyama Chuo Hospital, Tsuyama, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Naito, H., Nishikimi, M., Okada, Y., Maeyama, H., Kiguchi, T., Yorifuji, T., Nishida, K., Matsui, S., Kuroda, Y., Nishiyama, K., Iwami, T., Nakao, A., & JAAM R-CAST OHCA Trial Group (2025). Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA). BMJ Open, 15(8), e101809. https://doi.org/10.1136/bmjopen-2025-101809
Vancouver
Naito H, Nishikimi M, Okada Y, Maeyama H, Kiguchi T, Yorifuji T, et al. Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA). BMJ Open. 2025;15(8):e101809. doi:10.1136/bmjopen-2025-101809
BibTeX
@article{Naito2025,
author = {Naito, Hiromichi and Nishikimi, Mitsuaki and Okada, Yohei and Maeyama, Hiroki and Kiguchi, Takeyuki and Yorifuji, Takashi and Nishida, Kazuki and Matsui, Shigeyuki and Kuroda, Yasuhiro and Nishiyama, Kei and Iwami, Taku and Nakao, Atsunori and JAAM R-CAST OHCA Trial Group, JAAM R-CAST OHCA Trial Group},
title = {Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA)},
journal = {BMJ Open},
year = {2025},
volume = {15},
number = {8},
pages = {e101809},
doi = {10.1136/bmjopen-2025-101809}
}
EUVIMED